Merci pour votre question.
The clinical database is now available through international websites and registries.
We in Canada are in agreement with the recommendation of the International Federation of Pharmaceutical Manufacturers and Associations in publishing in these registries all the clinical trials that are conducted. This is also inclusive of studies that are not started, so that from the outset the protocol or the description of that study is also publicly available.
The fact that some of the studies might not appear in the literature does not mean they escape regulatory scrutiny, because all clinical trials, including the ones that are under way, are part of the new drug submission. So there is scrutiny of all clinical trials, and post-marketing as well—phase 4 trials—will be part of this database.
There can be access, as I mentioned, through portals such as the portal of the IFPMA, and also by Rx&D, but there are other international databases, such as that of NIH or those of the other international organizations. So there is that level of access and transparency.